Biomarkers 2015 - 6thInternational Conference on Biomarkers & Clinical Research

Team Biomarkers opens up the 6th chapter and call upon the medical, clinical and life science researchers towards taking the biomolecular signature set to a probable therapeutic discovery in Canada from August 31-September 02, 2015 to our eminent conference 6th International Biomarkers and Clinical Research. Biomarkers-2015 will have the thematic blend of “Lab to Industry as Biosignatures to Therapeutic Discovery”. OMICS Group International is a pioneer and leading science event organizer, which publishes around 400 open access journals and conducts over 300 Medical, Clinical, Engineering, Life Sciences, Pharmacy scientific conferences all over the globe annually with the support of more than 1000 scientific societies and 3.5 million followers to its credit.
Total market value of Biomarkers in 2014 is $5.95 Billion and it is expected to reach $30 Billion in 2020 growing at CAGR of 16% from 2014 to 2020. Biomarkers major verticals are usually supplied by market of application and market of services. Common Annual Growth Rate of more than 37% is gained by market for application and Common Annual Growth Rate of more than 39% are gained from the market of services. Thus the common annual growth is 49% by revenue. Nowadays scope of biomarkers has a vital role in efficacy of the therapeutic process all around the world. Establishing the standardization of drug development has a major role for the development of disease pathway. Also, Research portfolio of biomarkers discovery has an application in all the major scientific studies.